Methotrexate lot recalled
Bedford Laboratories has recalled one lot of preservative-free Methotrexate for Injection because the active ingredient was contaminated with low levels of the preservative ethylene glycol. The affected lot is #859142, with a September 2007 expiry. Health professionals should not distribute the 1-gm vials (NDC 55390-143-01) and should contact Bedford Labs for return instructions. The complete FDA MedWatch safety summary is at http://www.fda.gov/medwatch/safety/2005/safety05.htm#Methotrexate.
Driving Primary Vendor Compliance to Increase Pharmacy Purchasing Savings
April 17th 2025This white paper will examine some common—and costly—assumptions about vendor compliance. We’ll show that pharmacies must do more than meet the bare minimum to stay competitive. We’ll also discuss solutions that pharmacies can leverage to optimize compliance, drive savings from their primary vendor, unlock additional pharmacy savings and enhance purchasing.
